IRF7 and breast cancer: Furthermore, sustained activation of the IFN-β/IFNAR/IRF7 signaling axis in chemotherapy-treated ER-negative BC cells instigates a state in which tumor cells are likely controlled by immune-mediated mechanisms [39].